Howard D. Uderman - Concepedia

Author

Howard D. Uderman

Bristol-Myers Squibb (United States)

Also Known As

HOWARD UDERMAN, Howard D Uderman, Howard D. Uderman, Howard Uderman

Publications

466

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)Vanderbilt University Vanderbilt University Medical Center University Medical Center of Princeton

About

Howard D. Uderman is an author at Bristol-Myers Squibb (United States) specializing in pharmacotherapy, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	131
2	Pharmacology	7	7	131
3	Social Sciences	1	1	13
4	Neurology	1	1	25
5	Neuroscience	1	1	13

Howard D. Uderman

Publications

455

Citations

H-Index

Page 1

	Year	Citations
Pharmacokinetics and Pharmacodynamics of Irbesartan in Healthy Subjects Maria Rosaria Marino, Kathleen M. Langenbacher, Neville F. Ford, The Journal of Clinical Pharmacology	1998	70
A Dose‐Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Gatifloxacin in Healthy Adult Men Diptee A. Gajjar, Frank LaCreta, Howard D. Uderman, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2000	61
Plasma Distribution, Disappearance Half-Time, Metabolic Clearance Rate, and Degradation of Synthetic Ovine Corticotropin-Releasing Factor in Man* Wendell E. Nicholson, G. Stephen DeCherney, Richard V. Jackson, The Journal of Clinical Endocrinology & Metabolism	1983	50
Pharmacokinetics and Tolerability of Buspirone during Oral Administration to Children and Adolescents with Anxiety Disorder and Normal Healthy Adults Daniel E. Salazar, Edyta J. Frackiewicz, Randy Dockens, The Journal of Clinical Pharmacology	2001	48
Attenuation of the development of hypertension in spontaneously hypertensive rats by the thromboxane synthetase inhibitor, 4′-(imidazol-1-yl) acetophenone Howard D. Uderman, Robert J. Workman, Edwin K. Jackson Prostaglandins HypertensionCardiovascular DiseaseSodium HomeostasisMedicineThromboxane Synthetase Inhibitor	1982	35
Thromboxane Synthetase Inhibitor UK38,485 Lowers Blood Pressure in the Adult Spontaneously Hypertensive Rat Howard D. Uderman, Edwin K. Jackson, David Puett, Journal of Cardiovascular Pharmacology	1984	30
Pharmacokinetic and Pharmacodynamic Evaluation of Warfarin and Nefazodone Coadministration in Healthy Subjects Daniel E. Salazar, Randy Dockens, Rochelle L. Milbrath, The Journal of Clinical Pharmacology Healthy SubjectsPharmacodynamic EvaluationPharmacotherapyPharmacodynamic ModelingThrombosis	1995	25
Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor, omapatrilat in healthy subjects Wei‐Chi Liao, O. Vesterqvist, Carol Delaney, British Journal of Clinical Pharmacology	2003	24
Open‐Label, Nonrandomized Study of the Effects of Gatifloxacin on the Pharmacokinetics of Midazolam in Healthy Male Volunteers Dennis M. Grasela, Frank LaCreta, Georgia Kollia, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2000	21
Effects of Standard and Supratherapeutic Doses of Nelfinavir on Cardiac Repolarization: A Thorough QT Study Bharat Damle, Cecilia Fosser, Kaori Ito, The Journal of Clinical Pharmacology Non-pharmacological InterventionCardiac RepolarizationCardiovascular DiseaseCardiac MechanicQtc Interval	2009	19

Page 1